VAERS reports by lot

Novartis Vaccines Meningococcal lot ABXB36AA: VAERS reports

28 VAERS reports list lot ABXB36AA as a Novartis Vaccines Meningococcal vaccine, received between 2021-09-10 and 2022-11-18. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
28
Reports
4%
Marked serious
1
With a death outcome
10
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction1119%
General / Systemic (non-local)1017%
Cardiac / Cardiovascular814%
Gastrointestinal712%
Neurological610%
Respiratory59%
Dermatological (non-injection-site)59%
Musculoskeletal35%
Allergic / Anaphylactic23%
Psychiatric / Neuropsychiatric12%

Where reports came from

U.S. state of the reporter, where given (top 12).

California4
Arizona4
Texas2
Ohio2
North Carolina2
Michigan2
Iowa2
New Jersey2
Nevada1
Alabama1
Louisiana1
Florida1

Reports by month received

2021-092
2021-113
2021-122
2022-013
2022-045
2022-052
2022-062
2022-071
2022-087
2022-111

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.